Applied DNA Sciences, a biotechnology company based in Stony Brook, New York, specializes in DNA-based technology solutions and went public in 2001. It offers PCR-based diagnostics for COVID-19 and population-scale testing through its subsidiary, Applied DNA Clinical Labs.
APDN has been in the news recently: Applied DNA Sciences received a follow-on order valued at over $500,000 for its Linea™ DNA product, with expected deliveries in 2025. The company also regained compliance with Nasdaq's minimum bid price requirement by maintaining a price of $1.00 for 20 consecutive business days.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
